Video Experimental Relacionado
Updated: May 10, 2026
12:55
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
22.1K
100 años de leucemia linfoblástica aguda infantil en el Reino Unido
1Paediatric Haematology, Bristol Royal Hospital for Children, Bristol, UK.
Archives of disease in childhood
|February 23, 2026
Resumen
Durante el siglo pasado, la atención de la leucemia linfoblástica aguda pediátrica en el Reino Unido ha experimentado avances significativos. Los ensayos del Reino Unido han sido fundamentales para mejorar los resultados del tratamiento para los niños con esta afección.
Área de la Ciencia:
- Oncología Pediátrica Oncología Pediátrica.
- Los ensayos clínicos son ensayos clínicos.
- Investigación de la leucemia Investigación de la leucemia.
Sus antecedentes:
- La leucemia linfoblástica aguda (LLA) es un importante cáncer infantil.
- Históricamente, los resultados para la LLA pediátrica fueron pobres.
- Los avances en el tratamiento han mejorado dramáticamente las tasas de supervivencia.
Objetivo del estudio:
- Para revisar 100 años de desarrollo de cuidado pediátrico de la LLA en el Reino Unido.
- Para resaltar el papel del Reino Unido en todos los ensayos clínicos.
- Mostrar mejoras en la atención al paciente y los resultados.
Principales métodos:
- Revisión histórica de la atención pediátrica de la LLA en el Reino Unido.
- Análisis de las contribuciones de los ensayos de leucemia linfoblástica aguda del Reino Unido.
- Resumen de la evolución del tratamiento y mejoras en la atención de apoyo.
Principales resultados:
- Progreso demostrable en los protocolos pediátricos de tratamiento de ALL durante más de un siglo.
- Impacto significativo de los ensayos ALL del Reino Unido en las estrategias terapéuticas.
- Marcada mejora en las tasas de supervivencia y calidad de vida de los pacientes pediátricos.
Conclusiones:
- Los ensayos clínicos del Reino Unido han sido fundamentales para el avance de la atención pediátrica de la LLA.
- La investigación continua y los ensayos colaborativos son esenciales para un mayor progreso.
- El viaje de la atención pediátrica ALL en el Reino Unido representa un gran éxito en la oncología pediátrica.
Videos de Conceptos Relacionados
01:49Probability Laws
Overview
01:27Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
01:19Rh Blood Group
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:22Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
01:22Bacterial Meningitis I: Introduction
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...